Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I-II Study Using Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease

NCT01475162 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT01475162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01475162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I-II Study Using Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease
Lead sponsor
Medical College of Wisconsin
Phase
Phase 1/2
Overall status
Terminated
Start date
August 8, 2011
Completion date
September 29, 2018
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute graft versus host disease